Mr. Jonathan H. Chou, born in 1964, was appointed as our independent non-executive Director ("INED") on 3 September 2010.
Mr. Chou is a seasoned advisor, and finance executive with over 30 years of professional experience in international banking and various ascending leadership positions, from Fortune 500 companies to Asia-headquartered U.S. listed companies. He was most recently the CFO of UTAC Holdings Ltd., a global semiconductor assembly and test services provider.
Before his tenure at UTAC, Mr. Chou held the pivotal role of CFO at Kulicke & Soffa Industries (Nasdaq: KLIC), a $2B plus market capitalization company, from 2010 to 2018. K&S is a leading provider of semiconductor packaging and electronic assembly solutions supporting the global automotive, consumer, communications, computing, and industrial segments. His leadership was instrumental in the company's success, demonstrating his ability to drive results in high-pressure environments.
He started his career as a Management Associate at Citibank and spent over 10 years in banking. Subsequently, he held several senior finance leadership positions with Fortune 500 companies, including Honeywell, Tyco ADT, Lucent Technologies (Bell Labs), and the Public Service Enterprise Group (PSEG).
In January 2021, Mr. Chou was appointed as an independent non-executive director of MicroPort CardioFlow Medtech Corporation, a subsidiary of
the Company, which gained successful listing on the Hong Kong Stock Exchange on 4 February 2021.
Mr. Chou volunteers and serves as the current chairman (appointed in January 2025) on the board of directors of Emerging Markets Investors Alliance, a 501(c)(3) not-for-profit organization that enables institutional investors to support good governance, promote sustainable development, and improve investment performance in the governments and companies they invest in.
Mr. Chou holds a MBA from Duke University’s Fuqua School of Business and a B.A. in Economics from the University at Buffalo.